{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:48:05Z","timestamp":1791460085497,"version":"4.3.4"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangsu Provincial Medical Key Discipline Cultivation Unit","award":["JSDW202241"],"award-info":[{"award-number":["JSDW202241"]}]},{"DOI":"10.13039\/501100013094","name":"Science and Technology Planning Social Development Project of Zhenjiang City","doi-asserted-by":"publisher","award":["SH2025033"],"award-info":[{"award-number":["SH2025033"]}],"id":[{"id":"10.13039\/501100013094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-02915-y","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:36:06Z","timestamp":1777433766000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Metabolic reprogramming of Th17\/Treg imbalance in autoimmune thyroid diseases"],"prefix":"10.1186","volume":"24","author":[{"given":"Mengli","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"2","key":"2915_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli A, et al. Autoimmune thyroid disorders. Autoimmun Rev. 2015;14(2):174\u201380.","journal-title":"Autoimmun Rev"},{"key":"2915_CR2","doi-asserted-by":"crossref","unstructured":"Vargas-Uricoechea H. Molecular Mechanisms in Autoimmune Thyroid Disease. Cells. 2023;12(6):918.","DOI":"10.3390\/cells12060918"},{"key":"2915_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fendo.2017.00050","volume":"8","author":"SM Ferrari","year":"2017","unstructured":"Ferrari SM, et al. Environmental Issues in Thyroid Diseases. Front Endocrinol (Lausanne). 2017;8:50.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2915_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1210\/er.2013-1055","volume":"35","author":"SM McLachlan","year":"2014","unstructured":"McLachlan SM, Rapoport B. Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity. Endocr Rev. 2014;35(1):59\u2013105.","journal-title":"Endocr Rev"},{"issue":"2","key":"2915_CR5","doi-asserted-by":"publisher","first-page":"101743","DOI":"10.1016\/j.beem.2023.101743","volume":"37","author":"Y Wang","year":"2023","unstructured":"Wang Y, Fang S, Zhou H. Pathogenic role of Th17 cells in autoimmune thyroid disease and their underlying mechanisms. Best Pract Res Clin Endocrinol Metab. 2023;37(2):101743.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2915_CR6","doi-asserted-by":"crossref","unstructured":"Antonelli A, et al. Graves\u2019 disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Volume 34. Best Practice & Research Clinical Endocrinology & Metabolism; 2020. p. 101388. 1.","DOI":"10.1016\/j.beem.2020.101388"},{"issue":"6","key":"2915_CR7","doi-asserted-by":"publisher","first-page":"E952","DOI":"10.1152\/ajpendo.00023.2025","volume":"328","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, et al. Follicular helper T cells in Graves\u2019 disease: pathogenic mechanisms and therapeutic implications. Am J Physiol Endocrinol Metab. 2025;328(6):E952\u201361.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2915_CR8","doi-asserted-by":"publisher","first-page":"p4075522","DOI":"10.1155\/2022\/4075522","volume":"2022","author":"Y Cai","year":"2022","unstructured":"Cai Y, et al. The Frequency of Intrathyroidal Follicular Helper T Cells Varies with the Progression of Graves\u2019 Disease and Hashimoto\u2019s Thyroiditis. J Immunol Res. 2022;2022:p4075522.","journal-title":"J Immunol Res"},{"key":"2915_CR9","doi-asserted-by":"publisher","first-page":"102976","DOI":"10.1016\/j.jaut.2022.102976","volume":"134","author":"X Wei","year":"2023","unstructured":"Wei X, Niu X. T follicular helper cells in autoimmune diseases. J Autoimmun. 2023;134:102976.","journal-title":"J Autoimmun"},{"issue":"7090","key":"2915_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235\u20138.","journal-title":"Nature"},{"key":"2915_CR11","doi-asserted-by":"publisher","first-page":"1698027","DOI":"10.3389\/fimmu.2026.1698027","volume":"17","author":"T Peng","year":"2026","unstructured":"Peng T, Wang J, Lin Y. Taming autoimmune thyroiditis: cellular immunomodulation through MSCs, Tregs, and tolDCs. Front Immunol. 2026;17:1698027.","journal-title":"Front Immunol"},{"issue":"11","key":"2915_CR12","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s40618-021-01565-w","volume":"44","author":"M Siomkaj\u0142o","year":"2021","unstructured":"Siomkaj\u0142o M, et al. Effect of systemic steroid therapy in Graves\u2019 orbitopathy on regulatory T cells and Th17\/Treg ratio. J Endocrinol Invest. 2021;44(11):2475\u201384.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2915_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1055\/a-2117-7652","volume":"55","author":"A Chen","year":"2023","unstructured":"Chen A, Huang L, Zhang L. Helper T Cell 17 and Regulatory T Cell Levels in Peripheral Blood of Newly Diagnosed Patients with Autoimmune Thyroid Disease: A Meta-Analysis. Horm Metab Res. 2023;55(1):40\u201350.","journal-title":"Horm Metab Res"},{"key":"2915_CR14","doi-asserted-by":"crossref","unstructured":"Lee GR. The Balance of Th17 versus Treg Cells in Autoimmunity. Int J Mol Sci. 2018;19(3):730.","DOI":"10.3390\/ijms19030730"},{"issue":"1","key":"2915_CR15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41420-025-02403-1","volume":"11","author":"Y Shi","year":"2025","unstructured":"Shi Y, Zhang H, Miao C. Metabolic reprogram and T cell differentiation in inflammation: current evidence and future perspectives. Cell Death Discovery. 2025;11(1):123.","journal-title":"Cell Death Discovery"},{"key":"2915_CR16","doi-asserted-by":"publisher","first-page":"1211221","DOI":"10.3389\/fimmu.2023.1211221","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Huang H, Zhao Y. Interplay between metabolic reprogramming and post-translational modifications: from glycolysis to lactylation. Front Immunol. 2023;14:1211221.","journal-title":"Front Immunol"},{"key":"2915_CR17","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","volume":"11","author":"J Shan","year":"2020","unstructured":"Shan J, Jin H, Xu Y. T Cell Metabolism: A New Perspective on Th17\/Treg Cell Imbalance in Systemic Lupus Erythematosus. Front Immunol. 2020;11:1027.","journal-title":"Front Immunol"},{"issue":"1","key":"2915_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/toxsci\/kfy019","volume":"163","author":"J Duan","year":"2018","unstructured":"Duan J, et al. Exposure to DBP and High Iodine Aggravates Autoimmune Thyroid Disease Through Increasing the Levels of IL-17 and Thyroid-Binding Globulin in Wistar Rats. Toxicol Sci. 2018;163(1):196\u2013205.","journal-title":"Toxicol Sci"},{"issue":"4","key":"2915_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/eji.201545788","volume":"46","author":"R Wang","year":"2016","unstructured":"Wang R, Solt LA. Metabolism of murine TH 17 cells: Impact on cell fate and function. Eur J Immunol. 2016;46(4):807\u201316.","journal-title":"Eur J Immunol"},{"issue":"7","key":"2915_CR20","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi LZ, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011;208(7):1367\u201376.","journal-title":"J Exp Med"},{"issue":"5","key":"2915_CR21","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang EV, et al. Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011;146(5):772\u201384.","journal-title":"Cell"},{"issue":"4","key":"2915_CR22","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2022.02.015","volume":"34","author":"SM Hochrein","year":"2022","unstructured":"Hochrein SM, et al. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab. 2022;34(4):516\u2013e53211.","journal-title":"Cell Metab"},{"issue":"5","key":"2915_CR23","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.immuni.2021.04.008","volume":"54","author":"K Xu","year":"2021","unstructured":"Xu K, et al. Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses. Immunity. 2021;54(5):976\u201387. .e7.","journal-title":"Immunity"},{"key":"2915_CR24","doi-asserted-by":"crossref","unstructured":"Damasceno LEA et al. PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation. J Exp Med. 2020;217(10):e20190613.","DOI":"10.1084\/jem.20190613"},{"issue":"3","key":"2915_CR25","doi-asserted-by":"publisher","first-page":"112205","DOI":"10.1016\/j.celrep.2023.112205","volume":"42","author":"TY Huang","year":"2023","unstructured":"Huang TY, et al. Phosphoenolpyruvate regulates the Th17 transcriptional program and inhibits autoimmunity. Cell Rep. 2023;42(3):112205.","journal-title":"Cell Rep"},{"issue":"6","key":"2915_CR26","doi-asserted-by":"publisher","first-page":"115799","DOI":"10.1016\/j.celrep.2025.115799","volume":"44","author":"C Wang","year":"2025","unstructured":"Wang C, et al. The glycolytic reaction PGAM restrains Th17 pathogenicity and Th17-dependent autoimmunity. Cell Rep. 2025;44(6):115799.","journal-title":"Cell Rep"},{"key":"2915_CR27","doi-asserted-by":"crossref","unstructured":"Sun L, Fu J, Zhou Y. Metabolism Controls the Balance of Th17\/T-Regulatory Cells. Front Immunol. 2017;8:1632.","DOI":"10.3389\/fimmu.2017.01632"},{"issue":"7459","key":"2915_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","volume":"499","author":"H Zeng","year":"2013","unstructured":"Zeng H, et al. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature. 2013;499(7459):485\u201390.","journal-title":"Nature"},{"issue":"6","key":"2915_CR29","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","volume":"25","author":"A Angelin","year":"2017","unstructured":"Angelin A, et al. Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments. Cell Metab. 2017;25(6):1282\u201393. .e7.","journal-title":"Cell Metab"},{"issue":"5","key":"2915_CR30","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2017.10.017","volume":"47","author":"M Kishore","year":"2017","unstructured":"Kishore M, et al. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis. Immunity. 2017;47(5):875\u2013e88910.","journal-title":"Immunity"},{"key":"2915_CR31","doi-asserted-by":"crossref","unstructured":"Getachew F, Hu J, Benamar M. Metabolic regulation of regulatory T cells: mechanisms, heterogeneity, and implications in disease. Front Immunol. 2025;16:1729690.","DOI":"10.3389\/fimmu.2025.1729690"},{"key":"2915_CR32","doi-asserted-by":"publisher","first-page":"1687755","DOI":"10.3389\/fimmu.2025.1687755","volume":"16","author":"Y Hu","year":"2025","unstructured":"Hu Y, et al. Metabolic reprogramming as a therapeutic target for modulating the Th17\/Treg balance in autoimmune diseases: a comprehensive review. Front Immunol. 2025;16:1687755.","journal-title":"Front Immunol"},{"issue":"7","key":"2915_CR33","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","volume":"175","author":"MO Johnson","year":"2018","unstructured":"Johnson MO, et al. Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism. Cell. 2018;175(7):1780\u201395. e19.","journal-title":"Cell"},{"issue":"7851","key":"2915_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591(7851):645\u201351.","journal-title":"Nature"},{"issue":"4","key":"2915_CR35","doi-asserted-by":"publisher","first-page":"101600","DOI":"10.1016\/j.omtm.2025.101600","volume":"33","author":"K Tuomela","year":"2025","unstructured":"Tuomela K, et al. Lactic acid improves Treg manufacturing and in vivo function. Mol Ther Methods Clin Dev. 2025;33(4):101600.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"5","key":"2915_CR36","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","volume":"21","author":"S Ma","year":"2024","unstructured":"Ma S, et al. Cellular metabolism regulates the differentiation and function of T-cell subsets. Cell Mol Immunol. 2024;21(5):419\u201335.","journal-title":"Cell Mol Immunol"},{"issue":"11","key":"2915_CR37","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","volume":"20","author":"L Berod","year":"2014","unstructured":"Berod L, et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med. 2014;20(11):1327\u201333.","journal-title":"Nat Med"},{"issue":"6","key":"2915_CR38","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.celrep.2015.07.014","volume":"12","author":"Y Endo","year":"2015","unstructured":"Endo Y, et al. Obesity Drives Th17 Cell Differentiation by Inducing the Lipid Metabolic Kinase, ACC1. Cell Rep. 2015;12(6):1042\u201355.","journal-title":"Cell Rep"},{"issue":"3","key":"2915_CR39","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cmet.2019.07.004","volume":"30","author":"DA Nicholas","year":"2019","unstructured":"Nicholas DA, et al. Fatty Acid Metabolites Combine with Reduced \u03b2 Oxidation to Activate Th17 Inflammation in Human Type 2 Diabetes. Cell Metab. 2019;30(3):447\u2013e4615.","journal-title":"Cell Metab"},{"key":"2915_CR40","doi-asserted-by":"publisher","first-page":"108411","DOI":"10.1016\/j.pharmthera.2023.108411","volume":"245","author":"T Kanno","year":"2023","unstructured":"Kanno T, et al. Lipid metabolism in Th17 cell function. Pharmacol Ther. 2023;245:108411.","journal-title":"Pharmacol Ther"},{"key":"2915_CR41","doi-asserted-by":"crossref","unstructured":"Wang T et al. Lipid metabolism analysis reveals that DGAT1 regulates Th17 survival by controlling lipid peroxidation in uveitis. JCI Insight. 2025;10(7):e184072.","DOI":"10.1172\/jci.insight.184072"},{"issue":"2","key":"2915_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nchembio.1714","volume":"11","author":"X Hu","year":"2015","unstructured":"Hu X, et al. Sterol metabolism controls T(H)17 differentiation by generating endogenous ROR\u03b3 agonists. Nat Chem Biol. 2015;11(2):141\u20137.","journal-title":"Nat Chem Biol"},{"issue":"17","key":"2915_CR43","doi-asserted-by":"publisher","first-page":"eadk1045","DOI":"10.1126\/sciadv.adk1045","volume":"10","author":"T Abimannan","year":"2024","unstructured":"Abimannan T, et al. Sphingolipid biosynthesis is essential for metabolic rewiring during T(H)17 cell differentiation. Sci Adv. 2024;10(17):eadk1045.","journal-title":"Sci Adv"},{"issue":"3","key":"2915_CR44","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cmet.2018.06.002","volume":"28","author":"B Raud","year":"2018","unstructured":"Raud B, et al. Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation. Cell Metab. 2018;28(3):504\u2013e5157.","journal-title":"Cell Metab"},{"issue":"3","key":"2915_CR45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41590-019-0589-5","volume":"21","author":"H Wang","year":"2020","unstructured":"Wang H, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors. Nat Immunol. 2020;21(3):298\u2013308.","journal-title":"Nat Immunol"},{"issue":"7849","key":"2915_CR46","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41586-021-03235-6","volume":"591","author":"SA Lim","year":"2021","unstructured":"Lim SA, et al. Lipid signalling enforces functional specialization of T(reg) cells in tumours. Nature. 2021;591(7849):306\u201311.","journal-title":"Nature"},{"issue":"7785","key":"2915_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang S, et al. Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature. 2019;576(7785):143\u20138.","journal-title":"Nature"},{"issue":"4","key":"2915_CR48","doi-asserted-by":"publisher","first-page":"e23487","DOI":"10.1096\/fj.202301686RR","volume":"38","author":"F Hao","year":"2024","unstructured":"Hao F, et al. Exercise-induced \u03b2-hydroxybutyrate promotes Treg cell differentiation to ameliorate colitis in mice. Faseb j. 2024;38(4):e23487.","journal-title":"Faseb j"},{"issue":"6","key":"2915_CR49","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.celrep.2020.01.022","volume":"30","author":"B Shin","year":"2020","unstructured":"Shin B, et al. Mitochondrial Oxidative Phosphorylation Regulates the Fate Decision between Pathogenic Th17 and Regulatory T Cells. Cell Rep. 2020;30(6):1898. \u20131909.e4.","journal-title":"Cell Rep"},{"issue":"3","key":"2915_CR50","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.cell.2020.06.014","volume":"182","author":"L Wu","year":"2020","unstructured":"Wu L, et al. Niche-Selective Inhibition of Pathogenic Th17 Cells by Targeting Metabolic Redundancy. Cell. 2020;182(3):641\u2013e65420.","journal-title":"Cell"},{"issue":"77","key":"2915_CR51","doi-asserted-by":"publisher","first-page":"eabm8182","DOI":"10.1126\/sciimmunol.abm8182","volume":"7","author":"HS Hong","year":"2022","unstructured":"Hong HS, et al. OXPHOS promotes apoptotic resistance and cellular persistence in T\u2009<\u2009sub>H\u200917 cells in the periphery and tumor microenvironment. Sci Immunol. 2022;7(77):eabm8182.","journal-title":"Sci Immunol"},{"issue":"5","key":"2915_CR52","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cmet.2019.01.019","volume":"29","author":"U Kaufmann","year":"2019","unstructured":"Kaufmann U, et al. Calcium Signaling Controls Pathogenic Th17 Cell-Mediated Inflammation by Regulating Mitochondrial Function. Cell Metab. 2019;29(5):1104\u201318. .e6.","journal-title":"Cell Metab"},{"issue":"7666","key":"2915_CR53","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature23475","volume":"548","author":"T Xu","year":"2017","unstructured":"Xu T, et al. Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature. 2017;548(7666):228\u201333.","journal-title":"Nature"},{"issue":"5","key":"2915_CR54","doi-asserted-by":"publisher","first-page":"109911","DOI":"10.1016\/j.celrep.2021.109911","volume":"37","author":"MI Matias","year":"2021","unstructured":"Matias MI, et al. Regulatory T cell differentiation is controlled by \u03b1KG-induced alterations in mitochondrial metabolism and lipid homeostasis. Cell Rep. 2021;37(5):109911.","journal-title":"Cell Rep"},{"issue":"17","key":"2915_CR55","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1182\/bloodadvances.2023010083","volume":"7","author":"D Gupta","year":"2023","unstructured":"Gupta D, et al. Activated protein C modulates T-cell metabolism and epigenetic FOXP3 induction via \u03b1-ketoglutarate. Blood Adv. 2023;7(17):5055\u201368.","journal-title":"Blood Adv"},{"issue":"12","key":"2915_CR56","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao M, et al. Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 2012;26(12):1326\u201338.","journal-title":"Genes Dev"},{"issue":"112","key":"2915_CR57","doi-asserted-by":"publisher","first-page":"eads9456","DOI":"10.1126\/sciimmunol.ads9456","volume":"10","author":"J Saravia","year":"2025","unstructured":"Saravia J, et al. Mitochondrial and lysosomal signaling orchestrates heterogeneous metabolic states of regulatory T cells. Sci Immunol. 2025;10(112):eads9456.","journal-title":"Sci Immunol"},{"key":"2915_CR58","doi-asserted-by":"publisher","first-page":"101975","DOI":"10.1016\/j.mito.2024.101975","volume":"80","author":"X Zhao","year":"2025","unstructured":"Zhao X, et al. Mitochondrial mechanisms in Treg cell regulation: Implications for immunotherapy and disease treatment. Mitochondrion. 2025;80:101975.","journal-title":"Mitochondrion"},{"key":"2915_CR59","doi-asserted-by":"crossref","unstructured":"Song J, et al. Impact of Drp1-Mediated Mitochondrial Dynamics on T Cell Immune Modulation. Front Immunol; 2022;13:873834.","DOI":"10.3389\/fimmu.2022.873834"},{"issue":"7932","key":"2915_CR60","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-022-05264-1","volume":"610","author":"F Baixauli","year":"2022","unstructured":"Baixauli F, et al. An LKB1-mitochondria axis controls T(H)17 effector function. Nature. 2022;610(7932):555\u201361.","journal-title":"Nature"},{"issue":"7","key":"2915_CR61","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1038\/emboj.2011.25","volume":"30","author":"F Baixauli","year":"2011","unstructured":"Baixauli F, et al. The mitochondrial fission factor dynamin-related protein 1 modulates T\u2010cell receptor signalling at the immune synapse. EMBO J. 2011;30(7):1238\u201350.","journal-title":"EMBO J"},{"key":"2915_CR62","doi-asserted-by":"crossref","unstructured":"Atallah R, Gindlhuber J, Heinemann A. Succinate in innate immunity: linking metabolic reprogramming to immune modulation. Front Immunol, 2025;16:1661948.","DOI":"10.3389\/fimmu.2025.1661948"},{"issue":"6","key":"2915_CR63","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41590-025-02166-y","volume":"26","author":"H Wang","year":"2025","unstructured":"Wang H, et al. Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch. Nat Immunol. 2025;26(6):866\u201380.","journal-title":"Nat Immunol"},{"key":"2915_CR64","doi-asserted-by":"publisher","first-page":"102812","DOI":"10.1016\/j.arr.2025.102812","volume":"110","author":"M Waseem","year":"2025","unstructured":"Waseem M, et al. Crosstalk between oxidative stress, mitochondrial dysfunction, chromosome instability, and the activation of the cGAS-STING\/IFN pathway in systemic sclerosis. Ageing Res Rev. 2025;110:102812.","journal-title":"Ageing Res Rev"},{"issue":"25","key":"2915_CR65","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41388-025-03458-1","volume":"44","author":"J Saravia","year":"2025","unstructured":"Saravia J, Chi H. Immunometabolism of regulatory T cells in cancer. Oncogene. 2025;44(25):2011\u201324.","journal-title":"Oncogene"},{"issue":"8","key":"2915_CR66","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/s12276-024-01286-z","volume":"56","author":"YJ Kang","year":"2024","unstructured":"Kang YJ, et al. Inhibition of BCAT1-mediated cytosolic leucine metabolism regulates Th17 responses via the mTORC1-HIF1\u03b1 pathway. Exp Mol Med. 2024;56(8):1776\u201390.","journal-title":"Exp Mol Med"},{"issue":"1","key":"2915_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12964-024-02018-6","volume":"23","author":"D Nan","year":"2025","unstructured":"Nan D, et al. Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets. Cell Communication Signal. 2025;23(1):45.","journal-title":"Cell Communication Signal"},{"issue":"3","key":"2915_CR68","doi-asserted-by":"publisher","first-page":"e2655","DOI":"10.1038\/cddis.2016.222","volume":"8","author":"W Ren","year":"2017","unstructured":"Ren W, et al. Amino-acid transporters in T-cell activation and differentiation. Cell Death Dis. 2017;8(3):e2655.","journal-title":"Cell Death Dis"},{"key":"2915_CR69","doi-asserted-by":"publisher","first-page":"108817","DOI":"10.1016\/j.intimp.2022.108817","volume":"109","author":"T Owada","year":"2022","unstructured":"Owada T, et al. LAT1-specific inhibitor ameliorates severe autoimmune arthritis in SKG mouse. Int Immunopharmacol. 2022;109:108817.","journal-title":"Int Immunopharmacol"},{"key":"2915_CR70","doi-asserted-by":"crossref","unstructured":"Zhao C et al. Multiple Roles of the Stress Sensor GCN2 in Immune Cells. Int J Mol Sci. 2023;24(5):4285.","DOI":"10.3390\/ijms24054285"},{"key":"2915_CR71","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.bbi.2013.12.012","volume":"37","author":"H Orsini","year":"2014","unstructured":"Orsini H, et al. GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice. Behav Immun. 2014;37:177\u201386. Brain.","journal-title":"Behav Immun"},{"key":"2915_CR72","doi-asserted-by":"publisher","first-page":"990794","DOI":"10.3389\/fimmu.2022.990794","volume":"13","author":"J Bystrom","year":"2022","unstructured":"Bystrom J, et al. Metabolic requirements of Th17 cells and of B cells: Regulation and defects in health and in inflammatory diseases. Front Immunol. 2022;13:990794.","journal-title":"Front Immunol"},{"issue":"53","key":"2915_CR73","doi-asserted-by":"publisher","first-page":"41525","DOI":"10.1074\/jbc.M110.189944","volume":"285","author":"Z Yan","year":"2010","unstructured":"Yan Z, Garg SK, Banerjee R. Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells. J Biol Chem. 2010;285(53):41525\u201332.","journal-title":"J Biol Chem"},{"issue":"2","key":"2915_CR74","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.immuni.2015.07.017","volume":"43","author":"R Yang","year":"2015","unstructured":"Yang R, et al. Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis. Immunity. 2015;43(2):251\u201363.","journal-title":"Immunity"},{"issue":"1","key":"2915_CR75","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10545-009-9006-9","volume":"34","author":"MH Stipanuk","year":"2011","unstructured":"Stipanuk MH, Ueki I. Dealing with methionine\/homocysteine sulfur: cysteine metabolism to taurine and inorganic sulfur. J Inherit Metab Dis. 2011;34(1):17\u201332.","journal-title":"J Inherit Metab Dis"},{"issue":"16","key":"2915_CR76","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1016\/j.cell.2021.05.045","volume":"184","author":"A Wagner","year":"2021","unstructured":"Wagner A, et al. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity. Cell. 2021;184(16):4168\u2013e418521.","journal-title":"Cell"},{"issue":"1","key":"2915_CR77","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12950-025-00469-3","volume":"22","author":"P Bunyard","year":"2025","unstructured":"Bunyard P, Makrecka-Kuka M, McMillan L. The critical role of methylenetetrahydrofolate dehydrogenases in immune regulation and auto-immunity. J Inflamm. 2025;22(1):44.","journal-title":"J Inflamm"},{"issue":"1","key":"2915_CR78","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.immuni.2021.10.011","volume":"55","author":"A Sugiura","year":"2022","unstructured":"Sugiura A, et al. MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and function. Immunity. 2022;55(1):65\u2013e819.","journal-title":"Immunity"},{"issue":"11","key":"2915_CR79","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s11427-022-2323-4","volume":"66","author":"X Wang","year":"2023","unstructured":"Wang X, et al. m(6)A mRNA modification potentiates Th17 functions to inflame autoimmunity. Sci China Life Sci. 2023;66(11):2543\u201352.","journal-title":"Sci China Life Sci"},{"issue":"6","key":"2915_CR80","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich JD, et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol. 2010;185(6):3190\u20138.","journal-title":"J Immunol"},{"key":"2915_CR81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.molimm.2019.03.005","volume":"109","author":"H Shen","year":"2019","unstructured":"Shen H, Shi LZ. Metabolic regulation of T(H)17 cells. Mol Immunol. 2019;109:81\u20137.","journal-title":"Mol Immunol"},{"issue":"1","key":"2915_CR82","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12974-024-03016-8","volume":"21","author":"P-F Wang","year":"2024","unstructured":"Wang P-F, et al. Mitochondrial and metabolic dysfunction of peripheral immune cells in multiple sclerosis. J Neuroinflamm. 2024;21(1):28.","journal-title":"J Neuroinflamm"},{"key":"2915_CR83","doi-asserted-by":"crossref","unstructured":"Tian M et al. ACLY ubiquitination by CUL3-KLHL25 induces the reprogramming of fatty acid metabolism to facilitate iTreg differentiation. Elife, 2021;10:e62394.","DOI":"10.7554\/eLife.62394"},{"issue":"1","key":"2915_CR84","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/imr.12655","volume":"283","author":"B Raud","year":"2018","unstructured":"Raud B, et al. Fatty acid metabolism in CD8(+) T cell memory: Challenging current concepts. Immunol Rev. 2018;283(1):213\u201331.","journal-title":"Immunol Rev"},{"issue":"2","key":"2915_CR85","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4062\/biomolther.2023.222","volume":"32","author":"RH Pokhrel","year":"2024","unstructured":"Pokhrel RH, et al. AMPK Alchemy: Therapeutic Potentials in Allergy, Aging, and Cancer. Biomol Ther (Seoul). 2024;32(2):171\u201382.","journal-title":"Biomol Ther (Seoul)"},{"issue":"1","key":"2915_CR86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/MOT.0000000000000149","volume":"20","author":"B Priyadharshini","year":"2015","unstructured":"Priyadharshini B, Turka LA. T-cell energy metabolism as a controller of cell fate in transplantation. Curr Opin Organ Transpl. 2015;20(1):21\u20138.","journal-title":"Curr Opin Organ Transpl"},{"issue":"2","key":"2915_CR87","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1093\/toxsci\/kfx215","volume":"161","author":"AK Ehrlich","year":"2018","unstructured":"Ehrlich AK, et al. TCDD, FICZ, and Other High Affinity AhR Ligands Dose-Dependently Determine the Fate of CD4\u2009+\u2009T Cell Differentiation. Toxicol Sci. 2018;161(2):310\u201320.","journal-title":"Toxicol Sci"},{"key":"2915_CR88","doi-asserted-by":"crossref","unstructured":"Jia L et al. Mitochondrial Control for Healthy and Autoimmune T Cells. Cells. 2023;12(13):1800.","DOI":"10.3390\/cells12131800"},{"issue":"5","key":"2915_CR89","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1507\/endocrj.EJ18-0396","volume":"66","author":"T Zake","year":"2019","unstructured":"Zake T, et al. Upregulated tissue expression of T helper (Th) 17 pathogenic interleukin (IL)-23 and IL-1\u03b2 in Hashimoto\u2019s thyroiditis but not in Graves\u2019 disease. Endocr J. 2019;66(5):423\u201330.","journal-title":"Endocr J"},{"issue":"3","key":"2915_CR90","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1507\/endocrj.EJ19-0307","volume":"67","author":"Z Chen","year":"2020","unstructured":"Chen Z, et al. The proportion of peripheral blood Tregs among the CD4\u2009+\u2009T cells of autoimmune thyroid disease patients: a meta-analysis. Endocr J. 2020;67(3):317\u201326.","journal-title":"Endocr J"},{"issue":"2","key":"2915_CR91","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1210\/jc.2009-1719","volume":"95","author":"N Figueroa-Vega","year":"2010","unstructured":"Figueroa-Vega N, et al. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto\u2019s thyroiditis. J Clin Endocrinol Metab. 2010;95(2):953\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"2915_CR92","doi-asserted-by":"publisher","first-page":"919681","DOI":"10.3389\/fimmu.2022.919681","volume":"13","author":"X Ren","year":"2022","unstructured":"Ren X, Chen H. Changes in Th9 and Th17 lymphocytes and functional cytokines and their relationship with thyroid-stimulating hormone receptor antibodies at different stages of graves\u2019 disease. Front Immunol. 2022;13:919681.","journal-title":"Front Immunol"},{"issue":"1","key":"2915_CR93","doi-asserted-by":"publisher","first-page":"2620248","DOI":"10.1080\/08916934.2026.2620248","volume":"59","author":"H Bisnauthsing","year":"2026","unstructured":"Bisnauthsing H, et al. Roles of T cell subpopulations in thyroid eye disease. Autoimmunity. 2026;59(1):2620248.","journal-title":"Autoimmunity"},{"issue":"9","key":"2915_CR94","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1210\/jc.2005-2337","volume":"91","author":"M Marazuela","year":"2006","unstructured":"Marazuela M, et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab. 2006;91(9):3639\u201346.","journal-title":"J Clin Endocrinol Metab"},{"key":"2915_CR95","doi-asserted-by":"crossref","unstructured":"Kustrimovic N et al. Regulatory T Cells in the Pathogenesis of Graves\u2019 Disease. Int J Mol Sci. 2023;24(22):16432.","DOI":"10.3390\/ijms242216432"},{"issue":"2","key":"2915_CR96","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","volume":"50","author":"RJ Miragaia","year":"2019","unstructured":"Miragaia RJ, et al. Single-Cell Transcriptomics of Regulatory T Cells Reveals Trajectories of Tissue Adaptation. Immunity. 2019;50(2):493\u2013504. .e7.","journal-title":"Immunity"},{"issue":"2","key":"2915_CR97","doi-asserted-by":"publisher","first-page":"101773","DOI":"10.1016\/j.beem.2023.101773","volume":"37","author":"SM Ferrari","year":"2023","unstructured":"Ferrari SM, et al. Chemokines in thyroid autoimmunity. Best Pract Res Clin Endocrinol Metab. 2023;37(2):101773.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"2915_CR98","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","volume":"41","author":"K Yasuda","year":"2019","unstructured":"Yasuda K, Takeuchi Y, Hirota K. The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol. 2019;41(3):283\u201397.","journal-title":"Semin Immunopathol"},{"key":"2915_CR99","doi-asserted-by":"publisher","first-page":"659738","DOI":"10.3389\/fendo.2021.659738","volume":"12","author":"L Zhao","year":"2021","unstructured":"Zhao L, et al. Reversal of Abnormal CD4\u2009+\u2009T Cell Metabolism Alleviates Thyroiditis by Deactivating the mTOR\/HIF1a\/Glycolysis Pathway. Front Endocrinol (Lausanne). 2021;12:659738.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2915_CR100","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1089\/thy.2017.0286","volume":"28","author":"X Yang","year":"2018","unstructured":"Yang X, et al. SIRT1-Regulated Abnormal Acetylation of FOXP3 Induces Regulatory T-Cell Function Defect in Hashimoto\u2019s Thyroiditis. Thyroid. 2018;28(2):246\u201356.","journal-title":"Thyroid"},{"key":"2915_CR101","doi-asserted-by":"crossref","unstructured":"Wro\u0144ska K, Ha\u0142asa M, Szczuko M. The Role of the Immune System in the Course of Hashimoto\u2019s Thyroiditis: The Current State of Knowledge. Int J Mol Sci. 2024;25(13):6883.","DOI":"10.3390\/ijms25136883"},{"key":"2915_CR102","doi-asserted-by":"crossref","unstructured":"Srb N et al. Hypoxia-Inducible Factor 1-\u03b1 in Autoimmune Diseases-Insights from the Paradigm of Hashimoto\u2019s Thyroiditis: A Narrative Review. Med Sci (Basel). 2026;14(1):61.","DOI":"10.3390\/medsci14010061"},{"issue":"8","key":"2915_CR103","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s40618-023-02293-z","volume":"47","author":"C He","year":"2024","unstructured":"He C, et al. Notch signaling regulates Th17 cells differentiation through PI3K\/AKT\/mTORC1 pathway and involves in the thyroid injury of autoimmune thyroiditis. J Endocrinol Invest. 2024;47(8):1971\u201386.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2915_CR104","doi-asserted-by":"publisher","first-page":"2433628","DOI":"10.1080\/08916934.2024.2433628","volume":"58","author":"LN Li","year":"2025","unstructured":"Li LN, et al. N6-methyladenosine modification of THBS1 induced by affluent WTAP promotes Graves\u2019 ophthalmopathy progression through glycolysis to affect Th17\/Treg balance. Autoimmunity. 2025;58(1):2433628.","journal-title":"Autoimmunity"},{"issue":"4","key":"2915_CR105","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s40618-024-02501-4","volume":"48","author":"L Zhang","year":"2025","unstructured":"Zhang L, et al. The immune mechanism of the mTOR\/ACC1\/CPT1A fatty acid oxidation signaling pathway in Hashimoto\u2019s thyroiditis. J Endocrinol Invest. 2025;48(4):845\u201359.","journal-title":"J Endocrinol Invest"},{"key":"2915_CR106","doi-asserted-by":"publisher","first-page":"117894","DOI":"10.1016\/j.biopha.2025.117894","volume":"184","author":"A Hellmann","year":"2025","unstructured":"Hellmann A, et al. Evaluation of the effect of Hashimoto\u2019s Thyroiditis on fatty acids involved in inflammation in the thyroid tissue. Biomed Pharmacother. 2025;184:117894.","journal-title":"Biomed Pharmacother"},{"key":"2915_CR107","doi-asserted-by":"crossref","unstructured":"Cardo C et al. The relationship between cholesterol levels and thyroid eye disease. Eur Thyroid J. 2025;14(1):e240133.","DOI":"10.1530\/ETJ-24-0133"},{"issue":"12","key":"2915_CR108","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s40618-018-0915-z","volume":"41","author":"G Lanzolla","year":"2018","unstructured":"Lanzolla G, et al. Relationship between serum cholesterol and Graves\u2019 orbitopathy (GO): a confirmatory study. J Endocrinol Invest. 2018;41(12):1417\u201323.","journal-title":"J Endocrinol Invest"},{"key":"2915_CR109","doi-asserted-by":"publisher","first-page":"104858","DOI":"10.1016\/j.cellimm.2024.104858","volume":"403\u2013404","author":"B Liu","year":"2024","unstructured":"Liu B, Li L, Wang X. Petunidin suppresses Hashimoto\u2019s thyroiditis by regulating Th1\/Th17 homeostasis and oxidative stress. Cell Immunol. 2024;403\u2013404:104858.","journal-title":"Cell Immunol"},{"key":"2915_CR110","doi-asserted-by":"publisher","first-page":"114569","DOI":"10.1016\/j.intimp.2025.114569","volume":"155","author":"L Mou","year":"2025","unstructured":"Mou L, et al. Ursolic acid suppresses ferroptosis by modulating Th17\/Treg balance and gut dysbiosis in experimental autoimmune thyroiditis rats. Int Immunopharmacol. 2025;155:114569.","journal-title":"Int Immunopharmacol"},{"key":"2915_CR111","first-page":"2782","volume":"17","author":"CC Tsai","year":"2011","unstructured":"Tsai CC, et al. Increased response to oxidative stress challenge in Graves\u2019 ophthalmopathy orbital fibroblasts. Mol Vis. 2011;17:2782\u20138.","journal-title":"Mol Vis"},{"issue":"12","key":"2915_CR112","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1210\/jc.2016-1279","volume":"101","author":"U Berchner-Pfannschmidt","year":"2016","unstructured":"Berchner-Pfannschmidt U, et al. Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves\u2019 Ophthalmopathy\u2014Implications for Smoking. J Clin Endocrinol Metabolism. 2016;101(12):4834\u201342.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"2915_CR113","doi-asserted-by":"publisher","first-page":"1605739","DOI":"10.3389\/fimmu.2025.1605739","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang L, et al. Dysregulated tryptophan metabolism: driving T cell subsets and PI3K-Akt pathway alterations in Hashimoto\u2019s thyroiditis. Front Immunol. 2025;16:1605739.","journal-title":"Front Immunol"},{"issue":"1","key":"2915_CR114","doi-asserted-by":"publisher","first-page":"9945","DOI":"10.1038\/s41598-025-90467-5","volume":"15","author":"T Luo","year":"2025","unstructured":"Luo T, et al. Serum metabolomic analysis in patients with Hashimoto\u2019s thyroiditis positive for TgAb or TPOAb: a preliminary study. Sci Rep. 2025;15(1):9945.","journal-title":"Sci Rep"},{"issue":"8","key":"2915_CR115","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s40618-025-02593-6","volume":"48","author":"W Yang","year":"2025","unstructured":"Yang W, et al. Tryptophan metabolites exert potential therapeutic activity in graves\u2019 orbitopathy by ameliorating orbital fibroblasts inflammation and proliferation. J Endocrinol Invest. 2025;48(8):1781\u201395.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2915_CR116","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/qjmed\/hcu216","volume":"108","author":"YR Yan","year":"2015","unstructured":"Yan YR, et al. Iodine nutrition and thyroid diseases in Chengdu, China: an epidemiological study. QJM. 2015;108(5):379\u201385.","journal-title":"QJM"},{"issue":"1\u20133","key":"2915_CR117","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s12011-014-9958-y","volume":"159","author":"X Yang","year":"2014","unstructured":"Yang X, et al. Effect of iodine excess on Th1, Th2, Th17, and Treg cell subpopulations in the thyroid of NOD.H-2h4 mice. Biol Trace Elem Res. 2014;159(1\u20133):288\u201396.","journal-title":"Biol Trace Elem Res"},{"key":"2915_CR118","doi-asserted-by":"crossref","unstructured":"Wu Y et al. Iodine activates NLRP3 inflammasomes in PBMCs of patients with autoimmune thyroiditis and regulates Th1 and Th17 cell differentiation. Endocr Connect. 2025;14(2):e240456.","DOI":"10.1530\/EC-24-0456"},{"issue":"9","key":"2915_CR119","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/14728222.2024.2401518","volume":"28","author":"WD Xu","year":"2024","unstructured":"Xu WD, Yang C, Huang AF. The role of Nrf2 in immune cells and inflammatory autoimmune diseases: a comprehensive review. Expert Opin Ther Targets. 2024;28(9):789\u2013806.","journal-title":"Expert Opin Ther Targets"},{"key":"2915_CR120","doi-asserted-by":"publisher","first-page":"1554028","DOI":"10.3389\/fimmu.2025.1554028","volume":"16","author":"F Savagner","year":"2025","unstructured":"Savagner F, et al. Iron and energy metabolic interactions in Treg-mediated immune regulation. Front Immunol. 2025;16:1554028.","journal-title":"Front Immunol"},{"issue":"7","key":"2915_CR121","doi-asserted-by":"publisher","first-page":"12895","DOI":"10.3390\/ijms150712895","volume":"15","author":"Y Luo","year":"2014","unstructured":"Luo Y, et al. Iodine excess as an environmental risk factor for autoimmune thyroid disease. Int J Mol Sci. 2014;15(7):12895\u2013912.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2915_CR122","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1210\/er.2006-0044","volume":"28","author":"M Rotondi","year":"2007","unstructured":"Rotondi M, et al. Role of chemokines in endocrine autoimmune diseases. Endocr Rev. 2007;28(5):492\u2013520.","journal-title":"Endocr Rev"},{"key":"2915_CR123","doi-asserted-by":"crossref","unstructured":"Morasiewicz-Jeziorek J, et al. The Role of Immunological Challenges, Oxidative Stress, and Dietary Interventions in Managing Hashimoto\u2019s Thyroiditis: A Narrative Review. Nutr Rev; 2026:nuaf195.","DOI":"10.1093\/nutrit\/nuaf195"},{"issue":"3","key":"2915_CR124","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1210\/en.2004-1165","volume":"146","author":"H Kimura","year":"2005","unstructured":"Kimura H, et al. Expression of class II major histocompatibility complex molecules on thyrocytes does not cause spontaneous thyroiditis but mildly increases its severity after immunization. Endocrinology. 2005;146(3):1154\u201362.","journal-title":"Endocrinology"},{"issue":"1","key":"2915_CR125","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.1038\/s41467-024-50192-5","volume":"15","author":"R Mart\u00ednez-Hern\u00e1ndez","year":"2024","unstructured":"Mart\u00ednez-Hern\u00e1ndez R, et al. Unraveling the molecular architecture of autoimmune thyroid diseases at spatial resolution. Nat Commun. 2024;15(1):5895.","journal-title":"Nat Commun"},{"issue":"1","key":"2915_CR126","doi-asserted-by":"publisher","first-page":"16880","DOI":"10.1038\/s41598-022-19556-z","volume":"12","author":"K Torimoto","year":"2022","unstructured":"Torimoto K, et al. Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves\u2019 disease. Sci Rep. 2022;12(1):16880.","journal-title":"Sci Rep"},{"key":"2915_CR127","doi-asserted-by":"publisher","first-page":"1217253","DOI":"10.3389\/fphar.2023.1217253","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhao Q, Li B. Current and promising therapies based on the pathogenesis of Graves\u2019 ophthalmopathy. Front Pharmacol. 2023;14:1217253.","journal-title":"Front Pharmacol"},{"key":"2915_CR128","doi-asserted-by":"crossref","unstructured":"Smith TJ. TSHR-IGF-IR complex drives orbital fibroblast misbehavior in thyroid eye disease. Curr Opin Endocrinol Diabetes Obes. 2024;31(5):177\u2013183.","DOI":"10.1097\/MED.0000000000000878"},{"key":"2915_CR129","doi-asserted-by":"crossref","unstructured":"Zong Y et al. Teprotumumab for Thyroid Eye Disease: Mechanism, Clinical Efficacy, and Current Challenges. Antibodies (Basel). 2025;14(3):55.","DOI":"10.3390\/antib14030055"},{"key":"2915_CR130","doi-asserted-by":"publisher","first-page":"1537365","DOI":"10.3389\/fimmu.2025.1537365","volume":"16","author":"Z Peng","year":"2025","unstructured":"Peng Z, et al. PDK2-enhanced glycolysis aggravates fibrosis via IL11 signaling pathway in Graves\u2019 orbitopathy. Front Immunol. 2025;16:1537365.","journal-title":"Front Immunol"},{"key":"2915_CR131","doi-asserted-by":"crossref","unstructured":"G\u00f6rtz GE et al. Macrophage-Orbital Fibroblast Interaction and Hypoxia Promote Inflammation and Adipogenesis in Graves\u2019 Orbitopathy. Endocrinology. 2022;164(2):bqac203.","DOI":"10.1210\/endocr\/bqac203"},{"issue":"1","key":"2915_CR132","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s10792-025-03564-9","volume":"45","author":"J Dwivedi","year":"2025","unstructured":"Dwivedi J, et al. Molecular pathway and mechanism responsible for the progress of thyroid-associated orbitopathy. Int Ophthalmol. 2025;45(1):197.","journal-title":"Int Ophthalmol"},{"issue":"8","key":"2915_CR133","doi-asserted-by":"publisher","first-page":"100699","DOI":"10.1016\/j.xcrm.2022.100699","volume":"3","author":"Z Li","year":"2022","unstructured":"Li Z, et al. Single-cell RNA sequencing depicts the local cell landscape in thyroid-associated ophthalmopathy. Cell Rep Med. 2022;3(8):100699.","journal-title":"Cell Rep Med"},{"key":"2915_CR134","doi-asserted-by":"crossref","unstructured":"Liu Z et al. Dynamic transition of Tregs to cytotoxic phenotype amid systemic inflammation in Graves\u2019 ophthalmopathy. JCI Insight. 2024;9(22):e181488.","DOI":"10.1172\/jci.insight.181488"},{"issue":"4","key":"2915_CR135","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1530\/JME-20-0143","volume":"65","author":"R Ma","year":"2020","unstructured":"Ma R, et al. PDK2-enhanced glycolysis promotes fibroblast proliferation in thyroid-associated ophthalmopathy. J Mol Endocrinol. 2020;65(4):163\u201374.","journal-title":"J Mol Endocrinol"},{"key":"2915_CR136","doi-asserted-by":"crossref","unstructured":"Liu Z et al. Lactate metabolism and protein lactylation in cancer. Mol Biomed. 2026;7(1):15.","DOI":"10.1186\/s43556-026-00417-4"},{"issue":"12","key":"2915_CR137","doi-asserted-by":"publisher","first-page":"110986","DOI":"10.1016\/j.celrep.2022.110986","volume":"39","author":"J Gu","year":"2022","unstructured":"Gu J, et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells. Cell Rep. 2022;39(12):110986.","journal-title":"Cell Rep"},{"key":"2915_CR138","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fimmu.2018.00096","volume":"9","author":"T Zheng","year":"2018","unstructured":"Zheng T, et al. Increased Interleukin-23 in Hashimoto\u2019s Thyroiditis Disease Induces Autophagy Suppression and Reactive Oxygen Species Accumulation. Front Immunol. 2018;9:96.","journal-title":"Front Immunol"},{"issue":"2","key":"2915_CR139","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s12020-024-03761-z","volume":"85","author":"T Wang","year":"2024","unstructured":"Wang T, et al. Causality of blood metabolites and metabolic pathways on Graves\u2019 disease and Graves\u2019 ophthalmopathy: a two-sample Mendelian randomization study. Endocrine. 2024;85(2):786\u201393.","journal-title":"Endocrine"},{"key":"2915_CR140","doi-asserted-by":"publisher","first-page":"1225494","DOI":"10.3389\/fendo.2023.1225494","volume":"14","author":"V Kravchenko","year":"2023","unstructured":"Kravchenko V, Zakharchenko T. Thyroid hormones and minerals in immunocorrection of disorders in autoimmune thyroid diseases. Front Endocrinol (Lausanne). 2023;14:1225494.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2915_CR141","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1046\/j.1365-2265.2004.01978.x","volume":"60","author":"S Fountoulakis","year":"2004","unstructured":"Fountoulakis S, Tsatsoulis A. On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis. Clin Endocrinol (Oxf). 2004;60(4):397\u2013409.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2915_CR142","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","volume":"12","author":"A Perl","year":"2016","unstructured":"Perl A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol. 2016;12(3):169\u201382.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"2915_CR143","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/08916934.2020.1855428","volume":"54","author":"C Yongjun","year":"2021","unstructured":"Yongjun C, et al. Dioscin alleviates hashimoto\u2019s thyroiditis by regulating the SUMOylation of IRF4 to promote CD4(+)CD25(+)Foxp3(+) treg cell differentiation. Autoimmunity. 2021;54(1):51\u20139.","journal-title":"Autoimmunity"},{"issue":"7","key":"2915_CR144","doi-asserted-by":"publisher","first-page":"E1183","DOI":"10.1210\/jc.2013-4182","volume":"99","author":"L Zhang","year":"2014","unstructured":"Zhang L, et al. Possible targets for nonimmunosuppressive therapy of Graves\u2019 orbitopathy. J Clin Endocrinol Metab. 2014;99(7):E1183\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"2915_CR145","doi-asserted-by":"crossref","unstructured":"Zhang M et al. Rapamycin improves Graves\u2019 orbitopathy by suppressing CD4\u2009+\u2009cytotoxic T lymphocytes. JCI Insight. 2023;8(3):e160377.","DOI":"10.1172\/jci.insight.160377"},{"issue":"3","key":"2915_CR146","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s40618-024-02470-8","volume":"48","author":"S Comi","year":"2025","unstructured":"Comi S, et al. Long-term outcome of Graves\u2019 orbitopathy following treatment with sirolimus. J Endocrinol Invest. 2025;48(3):607\u201318.","journal-title":"J Endocrinol Invest"},{"key":"2915_CR147","doi-asserted-by":"publisher","first-page":"685522","DOI":"10.3389\/fcell.2021.685522","volume":"9","author":"X Jia","year":"2021","unstructured":"Jia X, et al. Metformin Reverses Hashimoto\u2019s Thyroiditis by Regulating Key Immune Events. Front Cell Dev Biol. 2021;9:685522.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"2915_CR148","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/08916934.2020.1789969","volume":"53","author":"X Jia","year":"2020","unstructured":"Jia X, Zhai T, Zhang JA. Metformin reduces autoimmune antibody levels in patients with Hashimoto\u2019s thyroiditis: A systematic review and meta-analysis. Autoimmunity. 2020;53(6):353\u201361.","journal-title":"Autoimmunity"},{"issue":"4","key":"2915_CR149","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1089\/thy.2017.0338","volume":"28","author":"YE Han","year":"2018","unstructured":"Han YE, et al. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase\/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves\u2019 Orbitopathy. Thyroid. 2018;28(4):528\u201336.","journal-title":"Thyroid"},{"issue":"5","key":"2915_CR150","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3803\/EnM.2024.1952","volume":"39","author":"J Lee","year":"2024","unstructured":"Lee J, et al. In Vitro Investigation of HIF-1\u03b1 as a Therapeutic Target for Thyroid-Associated Ophthalmopathy. Endocrinol Metab (Seoul). 2024;39(5):767\u201376.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"7","key":"2915_CR151","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41423-024-01183-5","volume":"21","author":"A Nakamura","year":"2024","unstructured":"Nakamura A, et al. HIF-1\u03b1 and MIF enhance neutrophil-driven type 3 immunity and chondrogenesis in a murine spondyloarthritis model. Cell Mol Immunol. 2024;21(7):770\u201386.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"2915_CR152","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cyto.2011.08.023","volume":"56","author":"H Liu","year":"2011","unstructured":"Liu H, et al. Blockade of hypoxia-inducible factor-1\u03b1 by YC-1 attenuates interferon-\u03b3 and tumor necrosis factor-\u03b1-induced intestinal epithelial barrier dysfunction. Cytokine. 2011;56(3):581\u20138.","journal-title":"Cytokine"},{"issue":"4","key":"2915_CR153","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1910434","volume":"382","author":"RS Douglas","year":"2020","unstructured":"Douglas RS, et al. Teprotumumab for the Treatment of Active Thyroid Eye Disease. N Engl J Med. 2020;382(4):341\u201352.","journal-title":"N Engl J Med"},{"issue":"6","key":"2915_CR154","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","volume":"15","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3 C, et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 2012;15(6):838\u201347.","journal-title":"Cell Metab"},{"key":"2915_CR155","doi-asserted-by":"publisher","first-page":"789740","DOI":"10.3389\/fimmu.2021.789740","volume":"12","author":"Y Shimojima","year":"2021","unstructured":"Shimojima Y, et al. Oxidative Stress Promotes Instability of Regulatory T Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Front Immunol. 2021;12:789740.","journal-title":"Front Immunol"},{"issue":"1","key":"2915_CR156","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cmet.2017.10.006","volume":"27","author":"S Chatterjee","year":"2018","unstructured":"Chatterjee S, et al. CD38-NAD(+)Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response. Cell Metab. 2018;27(1):85\u2013e1008.","journal-title":"Cell Metab"},{"key":"2915_CR157","doi-asserted-by":"crossref","unstructured":"Dwyer LR et al. CD38 expression by neonatal human na\u00efve CD4\u2009+\u2009T cells shapes their distinct metabolic and tolerogenic properties. J Clin Invest. 2026;136(8):e200062.","DOI":"10.1172\/JCI200062"},{"issue":"41","key":"2915_CR158","doi-asserted-by":"publisher","first-page":"E6145","DOI":"10.1073\/pnas.1607843113","volume":"113","author":"J Kaye","year":"2016","unstructured":"Kaye J, et al. Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A. 2016;113(41):E6145\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2915_CR159","doi-asserted-by":"publisher","first-page":"735","DOI":"10.17219\/acem\/68979","volume":"27","author":"R Kleszcz","year":"2018","unstructured":"Kleszcz R, et al. The inhibition of c-MYC transcription factor modulates the expression of glycolytic and glutaminolytic enzymes in FaDu hypopharyngeal carcinoma cells. Adv Clin Exp Med. 2018;27(6):735\u201342.","journal-title":"Adv Clin Exp Med"},{"issue":"9","key":"2915_CR160","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1080\/15384101.2016.1160975","volume":"15","author":"HS Madapura","year":"2016","unstructured":"Madapura HS, et al. cMyc-p53 feedback mechanism regulates the dynamics of T lymphocytes in the immune response. Cell Cycle. 2016;15(9):1267\u201375.","journal-title":"Cell Cycle"},{"issue":"6","key":"2915_CR161","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.immuni.2011.09.021","volume":"35","author":"R Wang","year":"2011","unstructured":"Wang R, et al. The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte Activation. Immunity. 2011;35(6):871\u201382.","journal-title":"Immunity"},{"key":"2915_CR162","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/S0959-8049(22)00924-8","volume":"174","author":"S Casacuberta Serra","year":"2022","unstructured":"Casacuberta Serra S, et al. MYC inhibition by OMO-103 induces immune cell recruitment in preclinical models of NSCLC and modulates the cytokine and chemokine profiles of Phase I patients showing stable disease. Eur J Cancer. 2022;174:S46\u20137.","journal-title":"Eur J Cancer"},{"key":"2915_CR163","doi-asserted-by":"crossref","unstructured":"Wang A et al. USP47 inhibits m6A-dependent c-Myc translation to maintain regulatory T cell metabolic and functional homeostasis. J Clin Invest. 2023;133(23):e169365.","DOI":"10.1172\/JCI169365"},{"issue":"18","key":"2915_CR164","doi-asserted-by":"publisher","first-page":"e2221352120","DOI":"10.1073\/pnas.2221352120","volume":"120","author":"W Zhang","year":"2023","unstructured":"Zhang W, et al. SRC2 controls CD4(+) T cell activation via stimulating c-Myc-mediated upregulation of amino acid transporter Slc7a5. Proc Natl Acad Sci U S A. 2023;120(18):e2221352120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2915_CR165","doi-asserted-by":"publisher","first-page":"103876","DOI":"10.1016\/j.autrev.2025.103876","volume":"24","author":"J Lin","year":"2025","unstructured":"Lin J, et al. Glycometabolic reprogramming of immune cells in autoimmune diseases. Autoimmun Rev. 2025;24(10):103876.","journal-title":"Autoimmun Rev"},{"key":"2915_CR166","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3389\/fimmu.2019.00833","volume":"10","author":"W Li","year":"2019","unstructured":"Li W, et al. Targeting T Cell Activation and Lupus Autoimmune Phenotypes by Inhibiting Glucose Transporters. Front Immunol. 2019;10:833.","journal-title":"Front Immunol"},{"issue":"2","key":"2915_CR167","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cmet.2019.10.015","volume":"31","author":"S Angiari","year":"2020","unstructured":"Angiari S, et al. Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4(+) T Cell Pathogenicity and Suppresses Autoimmunity. Cell Metab. 2020;31(2):391\u2013e4058.","journal-title":"Cell Metab"},{"issue":"10","key":"2915_CR168","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1039\/C9NP00008A","volume":"36","author":"A Naini","year":"2019","unstructured":"Naini A, Sasse F, Br\u00f6nstrup M. The intriguing chemistry and biology of soraphens. Nat Prod Rep. 2019;36(10):1394\u2013411.","journal-title":"Nat Prod Rep"},{"key":"2915_CR169","doi-asserted-by":"publisher","first-page":"1509408","DOI":"10.3389\/fimmu.2024.1509408","volume":"15","author":"S Peesari","year":"2024","unstructured":"Peesari S, McAleer JP. Regulation of human Th9 cell differentiation by lipid modulators targeting PPAR-\u03b3 and acetyl-CoA-carboxylase 1. Front Immunol. 2024;15:1509408.","journal-title":"Front Immunol"},{"issue":"1","key":"2915_CR170","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41385-020-0285-7","volume":"14","author":"P Mamareli","year":"2021","unstructured":"Mamareli P, et al. Targeting cellular fatty acid synthesis limits T helper and innate lymphoid cell function during intestinal inflammation and infection. Mucosal Immunol. 2021;14(1):164\u201376.","journal-title":"Mucosal Immunol"},{"issue":"Spe1","key":"2915_CR171","first-page":"e250075","volume":"70","author":"IB Silva","year":"2025","unstructured":"Silva IB, Puig-Domingo M. The impact of thyroid disorders on the gut microbiome: emerging mechanisms and clinical relevance. Arch Endocrinol Metab. 2025;70(Spe1):e250075.","journal-title":"Arch Endocrinol Metab"},{"key":"2915_CR172","doi-asserted-by":"publisher","first-page":"110588","DOI":"10.1016\/j.abb.2025.110588","volume":"773","author":"X Qi","year":"2025","unstructured":"Qi X, et al. Faecalibacterium prausnitzii alleviates Graves\u2019 orbitopathy by modulating short-chain fatty acid (SCFA) metabolism and inhibiting orbital fibrosis and adipogenesis. Arch Biochem Biophys. 2025;773:110588.","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"2915_CR173","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1007\/s13346-022-01284-6","volume":"13","author":"DA McBride","year":"2023","unstructured":"McBride DA, et al. Short-chain fatty acid-mediated epigenetic modulation of inflammatory T cells in vitro. Drug Delivery Translational Res. 2023;13(7):1912\u201324.","journal-title":"Drug Delivery Translational Res"},{"issue":"4","key":"2915_CR174","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.cmet.2020.07.001","volume":"32","author":"T Alissafi","year":"2020","unstructured":"Alissafi T, et al. Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in Autoimmunity. Cell Metab. 2020;32(4):591\u2013e6047.","journal-title":"Cell Metab"},{"issue":"6","key":"2915_CR175","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/cen.15128","volume":"101","author":"I Sharabati","year":"2024","unstructured":"Sharabati I, et al. The efficacy and safety of selenium supplementation versus placebo in the treatment of Graves\u2019 orbitopathy: A systematic review and meta-analysis of randomised controlled trials. Clin Endocrinol (Oxf). 2024;101(6):669\u201381.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2915_CR176","first-page":"265","volume":"2","author":"R Negro","year":"2008","unstructured":"Negro R. Selenium and thyroid autoimmunity. Biologics. 2008;2(2):265\u201373.","journal-title":"Biologics"},{"issue":"4","key":"2915_CR177","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s12276-023-00971-9","volume":"55","author":"J Jin","year":"2023","unstructured":"Jin J, et al. Targeting glutamine metabolism as a therapeutic strategy for cancer. Exp Mol Med. 2023;55(4):706\u201315.","journal-title":"Exp Mol Med"},{"key":"2915_CR178","doi-asserted-by":"crossref","unstructured":"Choi SC et al. Intrinsic T cell glutaminolysis promotes autoimmunity in lupus-prone mice. JCI Insight. 2025;10(21):e192286.","DOI":"10.1172\/jci.insight.192286"},{"issue":"2","key":"2915_CR179","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/cbf.654","volume":"14","author":"MC Werner","year":"1996","unstructured":"Werner MC, et al. Metabolism of glucose and glutamine in lymphocytes from Graves\u2019 hyperthyroid patients: influence of methimazole treatment. Cell Biochem Funct. 1996;14(2):97\u2013104.","journal-title":"Cell Biochem Funct"},{"key":"2915_CR180","doi-asserted-by":"publisher","first-page":"117864692211186","DOI":"10.1177\/11786469221118657","volume":"15","author":"G Sundaram","year":"2022","unstructured":"Sundaram G, et al. Prophylactic and Therapeutic Effect of Kynurenine for Experimental Autoimmune Encephalomyelitis (EAE) Disease. Int J Tryptophan Res. 2022;15:11786469221118657.","journal-title":"Int J Tryptophan Res"},{"issue":"10","key":"2915_CR181","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s40618-025-02647-9","volume":"48","author":"SY Liu","year":"2025","unstructured":"Liu SY, et al. METTL3 overexpression and ATF6 silencing-induced Inhibition in HAS2 expression relieves PDGF-BB stimulation-induced HA production and the proliferation of human orbital fibroblasts in graves\u2019 ophthalmopathy. J Endocrinol Invest. 2025;48(10):2337\u201350.","journal-title":"J Endocrinol Invest"},{"key":"2915_CR182","doi-asserted-by":"publisher","unstructured":"Yu LY et al. Small molecule activation of m6A mRNA methylation as a novel approach for neuroprotection. bioRxiv. 2023. https:\/\/doi.org\/10.1101\/2023.07.05.547860.","DOI":"10.1101\/2023.07.05.547860"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-02915-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02915-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-02915-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:23:59Z","timestamp":1781493839000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-02915-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":182,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2915"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-02915-y","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"13 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}